| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143316 | Lung Cancer | 2008 | 7 Pages |
Abstract
The stage IB lung adenocarcinoma patients without pleural invasion had a favorable outcome that was almost the same as that of stage IA patients. Because adverse effects of chemotherapy are sometimes severe and unacceptable, adjuvant chemotherapy can be omitted for stage IB adenocarcinoma without pleural invasion.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tetsuya Mizuno, Genichiro Ishii, Kanji Nagai, Junji Yoshida, Mitsuyo Nishimura, Takahiro Mochizuki, Osamu Kawai, Takahiro Hasebe, Atsushi Ochiai,